James D Welsh

Suggest Changes
Learn More
4055 Background: The value of PET after definitive chemoradiotherapy is still unclear. We hypothesized that the post-treatment pSUV and the percentage decrease SUV from baseline (dSUV) would(More)
4027 Background: Currently biomarker(s) cannot predict response to CTRT in EC patients thus treatment choices remain empiric. We assessed NF-kB, Gli-1, and sonic hedgehog (immuno-histochemistry) in(More)
82 Background: The value of iSUV of PET for predicting OS is unclear in patients with advanced esophageal or gastroesophageal carcinoma treated with definitive chemoradiotherapy. We tested the(More)
  • 1